Colchicine for Coronary Artery Disease: A Review.

Colchicine for Coronary Artery Disease: A Review.
复制标题

DOI:
10.3389/fcvm.2022.892588
复制
发表时间:
2022
影响因子:
3.6
通讯作者:
Yu, Bo
Yu, Bo
中科院分区:
医学3区
文献类型:
--
作者:
Chen, Tao;Liu, Guihong;Yu, Bo

文献摘要

参考文献

被引文献

相似文献

冠状动脉疾病严重威胁着人类的健康。越来越多的证据表明慢性炎症在该病的发生发展中起着关键作用。炎症标志物逐渐被用于诊断和治疗。虽然秋水仙碱治疗冠心病仍存在争议,但越来越多的研究表明,患者可以从这种药物中获益。本文就秋水仙碱的基本药理作用、抗炎作用机制、最重要的临床研究及最新进展作一综述。从这些文献来看,秋水仙碱有可能成为一种新的治疗冠心病的廉价药物。
Coronary artery disease is a serious threat to human health. More and more evidences indicate chronic inflammatory plays a key role in the development of this disease. Inflammation markers are gradually used in the diagnosis and treatment. Although the treatment of coronary heart disease with colchicine is still controversial, more and more studies showed that patients can benefit from this medicine. In this review, we discuss and summarize colchicine on essential pharmacology, anti-inflammatory mechanism of action, and the most important and recent clinical studies. According to these literatures, colchicine possibly will possibly become a new valuable and cheap medicine for the treatment of coronary artery disease.
DOI: 10.1093/eurjpc/zwab045
发表时间: 2021-03-29
影响因子: 8.3
作者:
Andreis, Alessandro;Imazio, Massimo;De Ferrari, Gaetano Maria
通讯作者: De Ferrari, Gaetano Maria
DOI: 10.2459/jcm.0000000000001157
发表时间: 2021-08-01
影响因子: 3
作者:
Andreis, Alessandro;Imazio, Massimo;De Ferrari, Gaetano M.
通讯作者: De Ferrari, Gaetano M.
DOI: 10.1001/jama.286.1.64
发表时间: 2001-07-04
影响因子: 120.7
作者:
Albert, MA;Danielson, E;Ridker, PM
通讯作者: Ridker, PM
DOI: 10.1073/pnas.83.7.2052
发表时间: 1986-04-01
影响因子: 11.1
作者:
BHATTACHARYYA, B;HOWARD, R;WOLFF, J
通讯作者: WOLFF, J
DOI: 10.1002/cbin.10988
发表时间: 2018-08-01
影响因子: 3.9
作者:
Chaldakov, George N.
通讯作者: Chaldakov, George N.